Institution profile

医療法人社団癒合会 高輪和合クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2606034 +4

Location

Prefecture
Tokyo
Address
港区高輪4丁目22番10号 小川商事ビル2階201号

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • CONCIDE 特定認定再生医療等委員
  • JSCSF再生医療等委員会
  • CONCIDE特定認定再生医療等委員会
  • +2

Public score

66.6/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
14.3 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 66.6
Public score →100

Registered technologies (5)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己頬脂肪由来幹細胞を用いた認知機能障害に対する治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己頬脂肪由来幹細胞を用いた認知機能障害に対する治療Stem cells (all sources)Adipose-derived stem cellsClass II
PRP and platelet-derived 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己多血小板血漿(PRP)による変形性関節症の治療PRP and platelet-derivedJoints and musculoskeletalClass II
自己血由来成分PRPを利用した口腔内組織の再生医療PRP and platelet-derivedDentalClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己多血小板血漿(PRP)による変形性関節症の治療PRP and platelet-derivedJoints and musculoskeletalClass II
Dental 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己血由来成分PRPを利用した口腔内組織の再生医療PRP and platelet-derivedDentalClass III

Certified committee for regenerative medicine

  • CONCIDE 特定認定再生医療等委員
  • JSCSF再生医療等委員会
  • CONCIDE特定認定再生医療等委員会
  • 特定非営利活動法人 先端医療推進機構 特定認定再生医療等委員会名古屋
  • 医療法人社団順朋会再生医療等委員会

Public document number

  • 01C2606034
  • 03C2607004
  • 02C2603027
  • 01C2407028
  • 03C2506009
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己頬脂肪由来幹細胞を用いた認知機能障害に対する治療Class IICONCIDE 特定認定再生医療等委員01C2606034
ヒト自己脂肪組織由来間葉系幹細胞を用いた疼痛緩和治療Class IIJSCSF再生医療等委員会03C2607004
慢性疼痛に対する自己脂肪由来幹細胞による治療Class IICONCIDE特定認定再生医療等委員会02C2603027
自己多血小板血漿(PRP)による変形性関節症の治療Class II特定非営利活動法人 先端医療推進機構 特定認定再生医療等委員会名古屋01C2407028
自己血由来成分PRPを利用した口腔内組織の再生医療Class III医療法人社団順朋会再生医療等委員会03C2506009

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor